Christopher P. Leamon

Abstract 4303: AZD2284: A novel, alpha-particle emitting radioconjugate targeting STEAP2 in metastatic castration-resistant prostate cancer

Darlene Monlish, Brigitte L. Thériault, Mel Ehudin, Vanessa Muniz‐Medina et autres

us, gb (code pays fourni par la source)

Abstract LB313: EGFRvIII-targeted alpha therapy shows significant therapeutic efficacy as both a single-agent and in combination with standard of care against preclinical GBM models

Julie Metcalf, Alexander F. Nielsen, Suma Prabhu, Nicole Robinson et autres

ca (code pays fourni par la source)

Abstract 5045: NTSR1-targeted alpha therapeutic [Ac-225]-FPI-2059 induces growth inhibition in a preclinical colorectal tumor model

Saleemulla Mahammad, Jaline Broqueza, Brigitte L. Thériault, John Forbes et autres

ca (code pays fourni par la source)

Abstract 5041: TEM-1 targeted alpha therapeutic [Ac-225]-FPI-1848 induces regression in pre-clinical sarcoma xenograft models

Sean Collens, Nicole Robinson, Matt Moran, Ryan Simms et autres

ca (code pays fourni par la source)

Supplementary Figures 1-4; Supplementary Tables 1 & 2 from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

Supplementary Figure Legends from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

Supplementary Figures 1-4; Supplementary Tables 1 & 2 from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

Supplementary Figure Legends from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

Supplementary Figures 1 through 8 from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy

Josefine Reber, Stephanie Haller, Christopher P. Leamon, Cristina Müller

Supplementary Tables 1 and 2 from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy

Josefine Reber, Stephanie Haller, Christopher P. Leamon, Cristina Müller

Supplementary Materials and Methods from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy

Josefine Reber, Stephanie Haller, Christopher P. Leamon, Cristina Müller

Supplementary Tables 1 and 2 from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy

Josefine Reber, Stephanie Haller, Christopher P. Leamon, Cristina Müller